NO20016052L - IL-8 receptor antagonists - Google Patents

IL-8 receptor antagonists

Info

Publication number
NO20016052L
NO20016052L NO20016052A NO20016052A NO20016052L NO 20016052 L NO20016052 L NO 20016052L NO 20016052 A NO20016052 A NO 20016052A NO 20016052 A NO20016052 A NO 20016052A NO 20016052 L NO20016052 L NO 20016052L
Authority
NO
Norway
Prior art keywords
receptor antagonists
antagonists
receptor
Prior art date
Application number
NO20016052A
Other languages
Norwegian (no)
Other versions
NO20016052D0 (en
Inventor
Katherine Louisa Widdowson
Gregory M Benson
Melvin C Rutledge
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO20016052L publication Critical patent/NO20016052L/en
Publication of NO20016052D0 publication Critical patent/NO20016052D0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
NO20016052A 1999-06-16 2001-12-11 IL-8 receptor antagonists NO20016052D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14002499P 1999-06-16 1999-06-16
PCT/US2000/016506 WO2000076501A1 (en) 1999-06-16 2000-06-15 Il-8 receptor antagonists

Publications (2)

Publication Number Publication Date
NO20016052L true NO20016052L (en) 2001-12-11
NO20016052D0 NO20016052D0 (en) 2001-12-11

Family

ID=22489379

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20016052A NO20016052D0 (en) 1999-06-16 2001-12-11 IL-8 receptor antagonists

Country Status (19)

Country Link
EP (1) EP1185265A4 (en)
JP (1) JP2003501463A (en)
KR (1) KR20020015347A (en)
CN (1) CN1356899A (en)
AR (1) AR024350A1 (en)
AU (1) AU766235B2 (en)
BR (1) BR0011122A (en)
CA (1) CA2377386A1 (en)
CO (1) CO5190696A1 (en)
CZ (1) CZ20014472A3 (en)
HU (1) HUP0201582A3 (en)
IL (1) IL145762A0 (en)
MX (1) MXPA01013005A (en)
NO (1) NO20016052D0 (en)
NZ (1) NZ514696A (en)
PL (1) PL352213A1 (en)
TR (1) TR200103638T2 (en)
WO (1) WO2000076501A1 (en)
ZA (1) ZA200109480B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20040570A1 (en) 2002-10-09 2004-08-30 Pharmacopeia Drug Discovery THIADIAZOLDIOXIDES AND THIADIAZOLOXIDES AS LIGANDS OF THE CXC- AND CC-CHEMOKIN RECEPTOR
US7094794B2 (en) 2003-07-28 2006-08-22 Sanofi-Aventis Deutschland Gmbh Substituted thiazole-benzoisothiazole dioxide derivatives, process for their preparation and their use
DE10334309A1 (en) * 2003-07-28 2005-03-03 Aventis Pharma Deutschland Gmbh Substituted thiazole-Benzoisothiazoldioxidderivate, processes for their preparation and their use
US7442709B2 (en) 2003-08-21 2008-10-28 Osi Pharmaceuticals, Inc. N3-substituted imidazopyridine c-Kit inhibitors
MXPA06002018A (en) 2003-08-21 2006-05-31 Osi Pharm Inc N-substituted benzimidazolyl c-kit inhibitors.
RU2006108791A (en) 2003-08-21 2006-07-27 Оси Фармасьютикалз, Инк. (Us) N-SUBSTITUTED PYRAZOLYLAMIDYLBENZIMIDAZOLYLES AS C-KIT INHIBITORS
CN1918138B (en) 2003-12-19 2011-05-04 先灵公司 Thiadiazoles as cxc- and cc- chemokine receptor ligands
CA2580690A1 (en) 2004-10-21 2006-05-04 Transtech Pharma, Inc. Bissulfonamide compounds as agonists of galr1, compositions, and methods of use
EP1831206B1 (en) 2004-12-01 2011-08-24 OSI Pharmaceuticals, Inc. N-substituted benzimidazolyl c-kit inhibitors and combinatorial benzimidazole library
IN2012DN01983A (en) 2009-08-24 2015-07-24 Ascepion Pharmaceuticals Inc
EP2377850A1 (en) 2010-03-30 2011-10-19 Pharmeste S.r.l. TRPV1 vanilloid receptor antagonists with a bicyclic portion
CN102060780B (en) * 2010-12-27 2014-11-05 雅本化学股份有限公司 Preparation method of 2-(N-substituted).-aminobenzimidazole derivative
CN111116502A (en) * 2018-10-30 2020-05-08 中国石油化工股份有限公司 One-step method for synthesizing benzotriazole

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA921120B (en) * 1991-02-19 1993-01-27 Smithkline Beecham Corp Cytokine inhibitors
IL131004A0 (en) * 1997-01-23 2001-01-28 Smithkline Beecham Corp Il-8 receptor antagonists

Also Published As

Publication number Publication date
CN1356899A (en) 2002-07-03
CA2377386A1 (en) 2000-12-21
JP2003501463A (en) 2003-01-14
MXPA01013005A (en) 2002-07-02
AU766235B2 (en) 2003-10-09
CO5190696A1 (en) 2002-08-29
WO2000076501A1 (en) 2000-12-21
PL352213A1 (en) 2003-08-11
IL145762A0 (en) 2002-07-25
CZ20014472A3 (en) 2002-06-12
NZ514696A (en) 2004-03-26
HUP0201582A3 (en) 2003-02-28
HUP0201582A2 (en) 2002-12-28
EP1185265A4 (en) 2004-02-04
AR024350A1 (en) 2002-10-02
ZA200109480B (en) 2002-11-18
NO20016052D0 (en) 2001-12-11
TR200103638T2 (en) 2002-04-22
KR20020015347A (en) 2002-02-27
BR0011122A (en) 2002-02-26
AU5616100A (en) 2001-01-02
EP1185265A1 (en) 2002-03-13

Similar Documents

Publication Publication Date Title
NO20001100D0 (en) IL-8 receptor antagonists
NO20025754L (en) IL-8 Receptor Antagonists
DE60216229D1 (en) IL-8 receptor antagonists
NO20016053L (en) IL-8 receptor antagonists
DE60112051D1 (en) IL-8 RECEPTOR ANTAGONISTS
DE60126480D1 (en) IL-8 RECEPTOR ANTAGONISTS
NO20016052L (en) IL-8 receptor antagonists
DE69838874D1 (en) IL-8 RECEPTOR ANTAGONISTS
MA25739A1 (en) IL-8 RECEPTOR ANTAGONISTS
DK1180028T3 (en) IL-8 receptor antagonists
DE69831413T2 (en) IL-8 RECEPTOR ANTAGONISTS
DE69824837D1 (en) IL-8 RECEPTOR ANTAGONISTS
NO20015774L (en) IL-8 receptor antagonists
MA25659A1 (en) IL-8 RECEPTOR ANTAGONISTS
NO20016065L (en) IL-8 receptor antagonists
NO20016102D0 (en) IL-8 receptor antagonists
NO20024366L (en) IL-8 receptor antagonists
NO20010353L (en) IL-8 receptor antagonist
SE0003996D0 (en) receptor Antagonists

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application